Table 2.
Feature | Office | Ambulatory | Home |
---|---|---|---|
Detection of white‐coat hypertension | − | ++ | ++ |
Detection of masked hypertension | − | ++ | ++ |
Assessment of nighttime BP level and dip | − | ++ | + |
Assessment of morning BP surge | − | ++ | − |
Assessment of morning hypertension | +/− | ++ | ++ |
Assessment of antihypertensive drug action | + | ++ | ++ |
Assessment of duration of drug action | +/− | ++ | + |
Long‐term follow‐up of hypertension | ++ | +/− | ++ |
Improvement of patients’ compliance | + | − | ++ |
Improvement of hypertension control rate | + | − | ++ |
Reproducibility | − | ++ | ++ |
Prognostic value | + | ++ | ++ |
Availability | ++ | − | ++ |
Cost | − | − | ++ |
BP, blood pressure.